Status lab-led Areas Viral Populations, Evolution and Transmission, Small RNA Biology and the Limits of Antiviral Silencing
Whether a virus survives a defence is normally studied one virus and one defence at a time, and the answer is usually an encoded antagonist. That leaves a prior question unasked. Given a pressure no virus in the comparison has evolved to antagonise, which feature of a replication strategy decides whether escape is available at all. Vertebrate cells make the experiment possible, because a vertebrate virus has no reason to carry a suppressor of silencing while the machinery is still present.
Benitez 2015 supplied the pressure and the first escape result, which is negative and set up everything after it. Across several designs, including one carrying a single target site, escape arose only by destroying guide production through deletion or excision of the hairpin, and no virus was recovered that had mutated the target sequence itself. Aguado 2018 made the pressure comparative, placing a cassette of perfectly complementary sites for five ubiquitous microRNAs in an essential transcript of six viruses from four families, with a reverse-orientation cassette of identical composition as the sequence-matched control and RNase III deficient fibroblasts as the silencing-off condition. A genome-wide CRISPR screen confirmed that the pressure runs through the microRNA machinery alone, recovering Drosha, Dicer, DGCR8, Argonaute 2, XPO5, TP53 and miR-21 and implicating no interferon genes. Sendai virus and influenza A virus lost more than five logs and were cleared, while Sindbis virus, a Semliki Forest virus chimera and poliovirus were suppressed and then recovered by precise excision. Poliovirus escaped despite making all its proteins from one RNA, so a multi-transcript genome organisation is not the requirement. The causal test is a single polymerase substitution, since poliovirus carrying D79H grew normally without the pressure, could not excise the cassette, and was undetectable by passage four. Template switching rather than polarity is therefore the requirement.
Uhl 2023 returned to the case Aguado 2018 had left as a dead end, on the argument that negative-sense RNA viruses do exist in hosts with functional antiviral silencing. Holding infections without passage so rare events are not diluted, and reading escape in 96-well format, a five-target Sendai virus escaped at six to eight days in roughly eight percent of wells. The signature was neither excision nor scattered point mutation but dense adenosine to guanosine changes confined to the target sites. Knockout of ADAR1 in a STAT1 deficient background abolished escape in all 96 wells and adenoviral reconstitution restored it, so the selective pressure is relieved by a host enzyme and the escape is not a viral adaptation at all. The same occurred with the cassette moved to the phosphoprotein gene, with editing on the antigenome, and in canine and mouse cells.
The practical consequence is that any design relying on microRNA targeting erodes in ways that differ by virus class, which Uhl 2023 states directly for vector design. Pham 2012 shows the same erosion in an animal, where dengue virus recovered from spleen carried no intact targeted genomes, only variants that had excised the whole cassette. What is not established is how ADAR1 comes to edit those particular sequences, with a duplex substrate model and a direct recruitment model both left open and the rarity of escape putting biochemistry out of reach. The route does not generalise, since a five-target influenza A virus under the same regime showed neither editing nor escape, which is unexplained. The proposal in Aguado 2018 that inefficient recombination explains the lower representation of negative-strand viruses across the tree of life is flagged as speculation by its authors, and the attribution of poor recombination to encapsidation is cited reasoning rather than a result.
Substantiated by - Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon Response, fixes the design parameters and establishes that escape occurs on the guide side rather than at the target - Homologous recombination is an intrinsic defense against antiviral RNA interference, makes the pressure comparative across four families and identifies template switching as the escape requirement with a single polymerase substitution - ADAR1 Biology Can Hinder Effective Antiviral RNA Interference, shows a host editing enzyme supplying escape to a virus that cannot recombine - Replication in Cells of Hematopoietic Origin Is Necessary for Dengue Virus Dissemination, shows total cassette excision under sustained pressure in an animal
Escape of a microRNA-targeted Sendai virus from engineered antiviral RNA interference comes not from the virus but from host ADAR1, whose adenosine to inosine editing destroys the target sites, and human ADAR1 also suppresses endogenous silencing in a plant.
Applying one uniform small RNA-based selective pressure to four virus families in vertebrate cells shows that the ability to escape it tracks with the capacity for polymerase template switching rather than with genome polarity as such, since positive-strand viruses excise the targeted sequence while negative-strand viruses are cleared and a recombination-defective poliovirus cannot escape.
Recreating a small RNA antiviral response in mice, using either host microRNAs repurposed as virus-specific guides or a virus-encoded artificial small interfering RNA, attenuates influenza A virus by more than five logs and prevents disease without any requirement for type I interferon signaling.
Inserting hematopoietic-specific miR-142 target sites into the dengue virus 3-prime untranslated region excludes replication from macrophages and dendritic cells in vivo and abolishes spread to other tissues, identifying hematopoietic cells as the dominant amplification compartment.